AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Drug-Induced Allergic Hepatitis Develops in Mice When Myeloid-Derived Suppressor Cells Are Depleted Prior to Halothane Treatment

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of PD‐1−/− mice with amodiaquine and anti‐CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients

  2015cited by this paper
• The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury.

  2014cited by this paper
• Thymic stromal lymphopoietin and interleukin‐4 mediate the pathogenesis of halothane‐induced liver injury in mice

  2014cited by this paper
• Pathogenic memory type Th2 cells in allergic inflammation.

  2014cited by this paper
• Liver auto-immunology: the paradox of autoimmunity in a tolerogenic organ.

  2013cited by this paper
• Eosinophils mediate the pathogenesis of halothane‐induced liver injury in mice

  2013influential reference
• Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations

  2013cited by this paper
• Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences

  2013cited by this paper
• Human leukocyte antigen (HLA)‐B*57:01‐restricted activation of drug‐specific T cells provides the immunological basis for flucloxacillin‐induced liver injury

  2013cited by this paper
• Animal models of idiosyncratic drug reactions.

  2012cited by this paper
• Innate and adaptive immune responses in asthma

  2012cited by this paper
• Halothane-induced hepatitis: A forgotten issue in developing countries

  2011cited by this paper
• Immunotherapeutic modulation of the suppressive liver and tumor microenvironments.

  2011cited by this paper
• Myeloid‐derived suppressor cell activation by combined LPS and IFN‐γ treatment impairs DC development

  2009cited by this paper
• Myeloid-derived suppressor cells as regulators of the immune system

  2009cited by this paper
• Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy

  2008cited by this paper
• Hepatoprotective role of endogenous interleukin-13 in a murine model of acetaminophen-induced liver disease.

  2007cited by this paper
• Role of neutrophils in a mouse model of halothane‐induced liver injury

  2006cited by this paper
• Role of CYP2E1 Immunoglobulin G4 Subclass Antibodies and Complement in Pathogenesis of Idiosyncratic Drug-Induced Hepatitis

  2006cited by this paper
• 5. IgE, mast cells, basophils, and eosinophils.

  2006cited by this paper
• Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species1

  2004cited by this paper
• Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity

  2004cited by this paper
• Tolerogenic role of Kupffer cells in allergic reactions.

  2003cited by this paper
• Immune-mediated drug-induced liver disease.

  2002cited by this paper
• Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

  2002cited by this paper
• Halothane-induced liver injury in outbred guinea pigs: role of trifluoroacetylated protein adducts in animal susceptibility.

  2001cited by this paper
• Eosinophil Major Basic Protein-1 Does Not Contribute to Allergen-Induced Airway Pathologies in Mouse Models of Asthma1

  2000cited by this paper
• Drug-induced “Allergic hepatitis”

  1995cited by this paper
• The calcium-binding protein calreticulin is covalently modified in rat liver by a reactive metabolite of the inhalation anesthetic halothane.

  1992cited by this paper
• Drug-specific T cells derived from patients with drug-induced allergic hepatitis.

  1992cited by this paper
• Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.

  1990cited by this paper
• IL-4 induces co-expression of intrinsic membrane IgG1 and IgE by murine B cells stimulated with lipopolysaccharide.

  1988cited by this paper
• Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane.

  1988cited by this paper
• An enzyme-linked immunosorbent assay for detection of antibodies against halothane-altered hepatocyte antigens.

  1984cited by this paper
• Evaluation of isoniazid-associated hepatitis by immunological tests.

  1978cited by this paper

• A Large-Scale Concordance Study of Toxicity Findings Across Preclinical Species and Humans for Small Molecules and Biologics in Drug Development

  2026influential citation
• Application of Raman spectroscopy and machine learning for determination of pro-toxicant activation in CYP2E1-expressing cells.

  2025cites this paper
• UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis

  2024cites this paper
• Dietary Supplement-Induced Hepatotoxicity: A Clinical Perspective

  2024cites this paper
• Rapamycin Antagonizes Angiogenesis and Lymphangiogenesis through Myeloid-Derived Suppressor Cells in Corneal Transplantation.

  2023cites this paper
• Gut microbiota affects sensitivity to immune-mediated isoniazid-induced liver injury.

  2023cites this paper
• Idiosyncratic Drug-Induced Liver Injury: From Pathogenesis to Risk Reduction

  2023cites this paper
• Immunophenotyping to improve the mechanistic understanding of idiosyncratic drug-induced liver injury: clinical implications and future directions

  2023cites this paper
• Hepatotoxicity due to herbal dietary supplements: Past, present and the future.

  2022cites this paper
• Roles of Cofactors in Drug-Induced Liver Injury: Drug Metabolism and Beyond

  2022cites this paper
• Special Section on Drug Metabolism in Liver Injury and Repair — Minireview Roles of Cofactors in Drug-Induced Liver Injury: Drug Metabolism and Beyond

  2022cites this paper
• Screening for Susceptibility-Related Biomarkers of Diclofenac-Induced Liver Injury in Rats Using Metabolomics

  2021cites this paper
• Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction

  2021cites this paper
• Potential Effects of Dietary Isoflavones on Drug-Induced Liver Injury

  2021cites this paper
• The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury

  2021cites this paper
• Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges

  2021cites this paper
• The hepatotoxicity of Polygonum multiflorum: The emerging role of the immune-mediated liver injury

  2020cites this paper
• Halothane anesthesia in children: is it still relevant?

  2020cites this paper
• What have we learned from animal models of idiosyncratic, drug-induced liver injury?

  2020cites this paper
• Drug‐Induced Liver Injury

  2020cites this paper
• Animal models of drug-induced liver injury.

  2019cites this paper
• Mechanisms of idiosyncratic drug-induced liver injury.

  2019cites this paper
• Drug-Induced Liver Disease: Mechanism and Diagnosis

  2019cites this paper
• Cell death in drug-induced liver injury.

  2019cites this paper
• Risk profiling using metabolomic characteristics for susceptible individuals of drug-induced liver injury caused by Polygonum multiflorum

  2019cites this paper
• Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors

  2019cites this paper
• Overview of Mechanisms of Drug-Induced Liver Injury (DILI) and Key Challenges in DILI Research

  2018cites this paper
• Strain and interindividual differences in lamotrigine‐induced liver injury in mice

  2018cites this paper
• The Effects of Immune Modulators on Amodiaquine-Induced Liver Injury.

  2018cites this paper
• Drug-Induced Liver Injury: Understanding the Different Immune-Mediated Phenotypes and Clinical Management

  2018cites this paper
• Editor’s Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI

  2018cites this paper
• Drugs and Toxins

  2018cites this paper
• Host Risk Modifiers in Idiosyncratic Drug-Induced Liver Injury (DILI) and Its Interplay with Drug Properties

  2018cites this paper
• An Animal Model of Abacavir-Induced HLA-Mediated Liver Injury

  2018cites this paper
• Immune mechanisms of idiosyncratic drug-induced liver injury

  2017cites this paper
• Mécanismes de l’hépatotoxicité médicamenteuse

  2017cites this paper
• Effects of immunization and checkpoint inhibition on amodiaquine-induced liver injury

  2017cites this paper
• Pathogenesis of Idiosyncratic Drug Induced Liver Injury

  2017cites this paper
• Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury

  2017cites this paper
• Synergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept Study

  2017cites this paper
• HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicity

  2017cites this paper
• JPET # 242354 1 Synergistic Cytotoxicity from Drugs and Cytokines in Vitro as an Approach to Classify Drugs According to their Potential to Cause Idiosyncratic Hepatotoxicity : A Proof of Concept Study

  2017cites this paper
• Human leukocyte antigen and idiosyncratic adverse drug reactions.

  2017cites this paper
• Human biology-based drug safety evaluation: scientific rationale, current status and future challenges

  2017cites this paper
• Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis

  2017influential citation
• Idiosyncratic Drug-Induced Liver Injury: Is Drug-Cytokine Interaction the Linchpin?

  2017cites this paper
• Immune Modulation by Volatile Anesthetics

  2016cites this paper
• Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications

  2016cites this paper
• Inhibition of immune tolerance unmasks drug‐induced allergic hepatitis

  2015cites this paper
• Xenobiotic and Endobiotic Mediated Interactions Between the Cytochrome P450 System and the Inflammatory Response in the Liver.

  2015influential citation
• Idiosyncratic Adverse Drug Reactions

  2014cites this paper
• Idiosyncratic Drug-Induced Liver Injury: Mechanisms and Susceptibility Factors

  2014cites this paper